CompoAtlas

Eponox

Retirée du marché américain le 28 September 2023 (selon le DSLD)

XL Xero Limits, food supplement from the US market

Label withdrawn from the US market. Eponox (XL Xero Limits), a food supplement au code-barres 891597002313, is described by its US market label. The French and European rules we can apply to this label flag no particular point. Doses of folates, niacine are not compared: their US units depend on the form. The formula sold in Europe under the same name may differ.

Official label. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.

Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.

Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.

If this product were sold in France

No point flagged by the rules we apply.

A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.

Label composition

Brand
XL Xero Limits
Barcode
891597002313
Form
Tablet
One serving
3 tablets
Servings
up to 3 servings per day
Other ingredients (in English, as written)
Microcrystalline Cellulose, Calcium Carbonate, Stearic Acid, Magnesium Stearate, Silica, Hydroxypropyl Methylcellulose, Titanium Dioxide, Triacetin
Ingredient (as written, in English)CategoryPer serving
NiacinVitamin75 mg
Vitamin B-6Vitamin25 mg
FolateVitamin800 µg
Vitamin B12Vitamin100 µg
IronMineral3 mg
EponoxBlend3.466 Gram(s)
Nitric Oxide Co-FactorsBlendnot stated
Arginine AKGOther substancenot stated
Arginine Ethyl EsterOther substancenot stated
L-Arginine HydrochlorideAmino acidnot stated
Gynostemma pentaphyllum extract (Gynostemma pentaphyllum)Plantnot stated
Cnidium monnieri powder (Cnidium monnieri)Plantnot stated
NorvalineAmino acidnot stated
CitrullineAmino acidnot stated
EPO Blood Building TechnologyBlendnot stated
Arachidonic AcidFatty acidnot stated
Echinacea pupurea extract (Echinacea purpurea)Plantnot stated
Portulaca oleracea extract (Portulaca oleracea)Plantnot stated
CobaltMineralnot stated
Pharmaceutical Meter Dose Controlled Delivery:
Hydrophilic Hypromellose PolymersOthernot stated

This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Echinacea pupurea extract
    Read the warning, when it applies and the studies cited

    ECHINACEA - ECHINACEA PURPUREA

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a progressive systemic disease such as tuberculosis, collagenosis, multiple sclerosis, or an immune system disorder (EMA 2015; Gardner and McGuffin 2013; Brinker 2010).

    3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking medications to suppress the immune system (Brinker 2010; Mills and Bone 2005).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Known adverse reactions

    Condition of application: Preparations containing herb top.

    Stop use if hypersensitivity/allergy occurs (MHRA 2018; EMA 2015; Kligler 2003; WHO 1999).

    4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 19 December 2025

They concern the ingredient, not this product or its dose. They do not replace medical advice.

List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).

Photograph the packaging

Brand : XL Xero Limits

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

List recorded in 2012. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line